Prior Authorization Added for LOQTORZI™

Holiday Closure

Our offices will be closed in observance of the Thanksgiving holiday on Thursday, Nov. 23 and Friday, Nov. 24. We will return to office, Monday, Nov. 27.


Prior Authorization Added for LOQTORZI™

Please note that BCBSWY requires authorization for LOQTORZI™ (toripalimab-tpzi). This is the first and only PD-1 inhibitor for the treatment of patients with recurrent or metastatic nasopharyngeal carcinoma.


Medical Policy Reminder

As a reminder, be sure to check our Medical Policy for regular updates. Our Medical Policy can be found at BCBSWY.com/providers/policy/

Share

Related Posts
Prior Authorization Update: Pharmacy Submissions Are Not Impacted
Important: While medical prior authorization submission requirements are changing October 1, 2026, the method of prior authorization requests for medications dispensed through a pharmacy are policy-dependent: BlueSelect…
Prior Authorization Submission Changes (Effective October 1)
Effective October 1, 2026, all Wyoming providers are required to submit initial prior authorization and concurrent review requests through Availity. Faxed requests from in-state providers…
Preferred Specialty Pharmacy Transitioning to Prime Therapeutics Pharmacy
Starting October 1, 2026, BCBSWY’s preferred Specialty Pharmacy will transition to Prime Therapeutics Pharmacy (PTP).  By partnering with PTP, BCBSWY is strengthening its specialty pharmacy program…

Fewer Hassles. Better Service.

ACA – Online Event Registration Form

Please enable JavaScript in your browser to complete this form.
Name
Email
How did you hear about this event?
Medicare - Event Registration
Medicare - Online Event Registration Form
Please enable JavaScript in your browser to complete this form.
Name
Email
How did you hear about this event?